Drug recall · December 26, 2018
infants* IBUPROFEN recall
Why: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-23, UPC 0 78742 02016 7.
- Lots / codes
Lot #: 00717009A, Exp 02/19; 00717015A, Exp 04/19; 00717024A, Exp 08/19
- Quantity
- 164,304 bottles
- Company
- Tris Pharma Inc., Monmouth Junction, NJ
- Distribution
- One distributor in PA who further distributed Nationwide in the USA.
- Initiated
- November 26, 2018 · Voluntary: Firm initiated
- Classified
- December 17, 2018
- Reported
- December 26, 2018
- Ended
- April 1, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ibuprofen
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.